Intracellular calcium, endothelial cells and angiogenesis

Recent Patents on Anti-Cancer Drug Discovery

Volumn 1, Issue 1, 2006, Pages 105-119

  Munaron, Luca ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Angiogenesis; Calcium; Eicosanoids; Endothelial cells; Nitric oxide; Signal transduction; Tyrosine kinase receptors

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC PROTEIN; ARACHIDONIC ACID; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; MITOGENIC AGENT; NITRIC OXIDE;

ANGIOGENESIS; ANIMAL; CALCIUM SIGNALING; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATENT; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; ARACHIDONIC ACID; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; ENDOTHELIAL CELLS; HUMANS; MITOGENS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; PATENTS AS TOPIC;

EID: 33846596009     PISSN: 15748928     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489206775246502     Document Type: Review

References (196)

1. Roos, J., Stauderman, K.A., Velicelebi, G., Ohlsen, K.L., Digregorio, P.: WO04078995A2 (2004).
2. Mikoshiba, K., Iwasaki, H., Maruyama, T., Hamano, S.-I.: US20040259842A1 (2004).
3. Berridge MJ, Bootman MD, Lipp P. Calcium: a life and death signal Nature 1998; 395: 645-648.
4. Kohn EC, Alessandro R, Spoonster J, Wersto RP, Liotta LA. Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci USA 1995; 92: 1307-1311.
5. Patton AM, Kassis J, Doong H, Kohn EC. Calcium as a molecular target in angiogenesis. Curr Pharm Des. 2003; 9: 543-51.
6. Estacion M, Mordan, LJ. Competence induction by PDGF requires sustained calcium influx by a mechanism distinct from storage-dependent calcium influx Cell Calcium 1993; 14: 439-454.
7. Kojima I, Mogami H, Shibata H, Ogata E. Role of calcium entry and protein kinase C in the progression activity of insulin-like growth factor-I J Biol Chem 1993; 268: 1003-1006.
8. Barbiero G, Munaron L, Antoniotti S, Baccino FM, Bonelli G, Lovisolo D. Role of mitogen-induced calcium influx in the control of the cell cycle in Balb-c 3T3 fibroblasts. Cell Calcium 1995; 18: 542-556.
9. Lovisolo D, Distasi C, Antoniotti S, Munaron L, Mitogens and calcium channels, News Physiol Sci 1997; 12: 279-285.
10. Whitaker M and Larman MG. Calcium and mitosis seminars in cell & developmental biology 2001; 12: 53-58.
11. Munaron L. Calcium signaling and control of cell proliferation by tyrosine kinase receptors, Int J Mol Med 2002; 10: 671-676.
12. Berridge MJ. Calcium signalling and cell proliferation, BioEssays 1995; 17: 491-500.
13. Kahl CR, Means AR. Regulation of cell cycle progression by calcium/calmodulin-dependent pathways, Endocr Rev 2003; 24: 719-736.
14. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nature reviews 2000; 1: 11-21.
15. Santella, L. The role of calcium in the cell cycle: facts and hypotheses Biochem Biophys Res Comm. 1998; 244: 317-324.
16. Rudolf R, Mongillo M, Rizzuto R, Pozzan T. Looking forward to seeing calcium, Nat Rev Mol Cell Biol. 4; 2003: 579-586.
17. Hryshko LV, Philipson KD. Sodium-calcium exchange: recent advances. Basic Res Cardiol. 1997; 92 Suppl 1: 45-51.
18. Mikoshiba, K., Hirota, J., Ando, H.: WO04103393A1 (2004).
19. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993; 361: 315-25.
20. Verkhratsky A and Shmigol A. Calcium-induced calcium release in neurons. Cell Calcium 1996; 19: 1-14.
21. Fiorio Pla A, Munaron L. Calcium influx, arachidonic acid, and control of endothelial cell proliferation. Cell Calcium 2001; 30: 235-244.
22. Antoniotti S, Fiorio Pla A, Pregnolato S, Mottola A, Lovisolo D, Munaron L. Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: a pharmacological approach. J Cell Physiol 2003; 197: 370-378.
23. Curtis BM, Catterall WA. Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules. Biochem 1984; 23: 2113-2118.
24. 2+ channels. Annu Rev Cell Dev Biol. 2000; 16: 521-55.
25. + channel Nature 2003; 423: 33-41.
26. Hille, B. Ion channels of excitable membranes. Sinauer Associates, Inc.: Sunderland, 2001.
27. 2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneously diabetic Goto-Kakizaki rats. Atheroscl 1997; 131: 167-175.
28. Corsini A, Bonfatti M, Quarato P, et al. Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes. J Cardiovasc Pharmacol 1996; 28: 687-694.
29. Mathov I, Plotkin LI, Sgarlata CL, Leoni J, Bellido T. Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro. J Bone Miner Res 2001; 16: 2050-2056.
30. Zhou X, Ono H, Ono Y, Frohlich ED. N-and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model. J Hypertens 2002; 20: 993-1000.
31. Roth-Eichhorn S, Eberheim A, Bode HP, Gressner AM. Transformation-dependent calcium influx by voltage-operated calcium channels in stellate cells of rat liver. J Hepatol 1999; 30: 612-620.
32. 2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol Pharmacol 2002; 62: 210-219.
33. Chemin J, Monteil A, Briquaire C, et al. Overexpression of Ttype calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation. FEBS Lett 2000; 478: 166-172.
34. Chen CF, Corbley MJ, Roberts TM, Hess P. Voltage-sensitive calcium channels in normal and transformed 3T3 fibroblasts. Science 1988; 239: 1024-1026.
35. 2+ channel. J Biol Chem 1999; 274: 15694-15700.
36. Zitt C, Halaszovich CR, Luckhoff A. The TRP family of cation channels: probing and advancing the concepts on receptoractivated calcium entry. Prog Neurobiol. 2002; 66: 243-64.
37. Vasquez G, Wedel BJ, Trebak M, St John Bird G, Putney JW Jr. Expression level of the canonical transient receptor potential 3 (TRPC3) channel determines its mechanism of activation. J Biol Chem 278: 21649-54, 2003.
38. 2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin. J Physiol 1999; 517: 121-134.
39. Shuttleworth TJ, Mignen O. Calcium entry and the control of calcium oscillations. Biochem Soc Trans 2003; 31: 916-919.
40. Penner R, Fasolato C, Hoth M. Calcium influx and its control by calcium release. Curr Opin Neurobiol 1993; 3: 368-374.
41. Holmuhamedov E, Lewis L, Bienengraeber M, Holmuhamedova M, Jahangir A, Terzic A. Suppression of human tumor cell proliferation through mitochondrial targeting. FASEB J 2002; 16: 1010-1016.
42. 2+ currents in rat basophilic leukaemia cells cultured under serum-free conditions. Cell Calcium 2001; 30: 141-150.
43. Furst J, Haller T, Chwatal S, et al. Simvastatin inhibits malignant transformation following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. Cell Physiol Biochem 2002; 12: 19-30.
44. 2+ entry in bronchial contraction and remodeling. J Appl Physiol. 2002; 92: 1594-1602.
45. Snutch, T.P.: US6617322 (2003).
46. Ji, Y.-H., Natarajan, M., Griffin, J.H., Jenkins, T.E.: US6897305 (2005).
47. 2+ATPase regulation. J Biol Chem 1996; 271: 27788-27794.
48. Munaron L, Fiorio Pla A. Calcium influx induced by activation of tyrosine kinase receptors in cultured bovine aortic endothelial cells J Cell Physiol 2000; 185: 454-463.
49. 2+ influx and cell proliferation in rat aortic smooth muscle cell lines. Eur J Pharmacol 1999; 379: 199-209.
50. 2+ entry channel. J Biol Chem 2000; 275: 9114-9119.
51. 2+ entry pathways via nitric oxide, Cell Signal 2004; 16: 157-165.
52. 2+ uptake in bovine vascular endothelial cells. J Physiol 2002; 539: 77-91.
53. Montell C, Rubin GM. Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 1989; 2: 1313-1323.
54. Clapham DE, Runnels LW, Strubing C. The TRP ion channel family. Nat Rev Neurosci 2001; 2: 387-96.
55. Clapham DE. TRP channels as cellular sensors. Nature 2003; 426: 517-24.
56. Hofmann T, Schaefer M, Schultz G, Gudermann T. Subunit composition of mammalian transient receptor potential channels in living cells. Proc Natl Acad Sci USA 2002; 99: 7461-66.
57. Chyb S, Raghu P, Hardie RC. Polyunsaturated fatty acids activate the Drosophila light-sensitive channels TRP and TRPL. Nature 1999; 397: 255-59.
58. Wu X, Babnigg G, Zagranichnaya T, Villereal ML. The role of endogenous human Trp4 in regulating carbachol-induced calcium oscillations in HEK-293 cells. J Biol Chem 2002; 277: 13597-608.
59. Antoniotti S, Lovisolo D, Fiorio Pla A, Munaron L. Expression and functional role of TRPC1 channels in native endothelial cells. FEBS Lett 2002; 510: 189-95.
60. 2+ entry in human arterial myocytes. Am J Physiol. 1999; 277: C343-C349.
61. 2+ entry and attenuates pulmonary artery smooth muscle cell proliferation Am J. Physiol Lung Cell Mol Physiol 2002; 283: L144-55.
62. Buess M, Engler O, Hirsh hH, Moroni C. Search for oncogenic regulators in an autocrine tumor model using differential display PCR: identification of novel candidate genes including the calcium channel mtrp6. Oncogene 1999; 18: 1487-94.
63. Kanzaki M, Zhang YQ, Mashima H, Li L, Shibata H, Kojima I. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I Nat Cell Biol 1999; 1: 165-70.
64. Kojima I, Matsunaga H, Kurokawa K, Ogata E, Nishimoto I. Calcium influx: an intracellular message of the mitogenic action of insulin-like growth factor-I. J Biol Chem 1988; 263: 16561-16567.
65. Moll V, Weick M, Milenkovic I, Kodal H, Reichenbach A, Bringmann A. P2Y receptor-mediated stimulation of Muller glial DNA synthesis. Invest Ophthalmol Vis Sci 2002; 43: 766-73.
66. Weiss H, Amberger A, Widschwendter M, Margreiter R, Ofner D, Dietl P. Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cells. Int J Cancer 2001; 92: 877-882.
67. 2+ mobilization. J Gastrointest Surg 2000; 4: 150-61.
68. 2+ influx of U937 cells. FEBS Lett 1996; 394: 159-64.
69. Cui, D., Davis, M.R., Dunn, M., et al.: US6680323 (2004).
70. Kruse HJ, Bauriedel G, Heimerl J, Hofling B, Weber PC. Role of L-type calcium channels on stimulated calcium influx and on proliferative activity of human coronary smooth muscle cells. J Cardiovasc Pharmacol 1994; 24: 328-335.
71. Kohn EC, Jacobs W, Kim YS, Alessandro R, Stetler-Stevenson WG, Liotta LA. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). J Biol Chem 1994; 269: 21505-11.
72. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategy for prevention and intervention. Cancer Res 1995; 55: 1856-62.
73. Kohn EC, Liotta LA. L651582: A novel antiproliferative and antimetastasis agent. J Natl Cancer Inst 1990; 82: 54-60.
74. Kohn, E.C., Liotta, L.A., Kim, Y.S.: US5652223 (1997).
75. Kohn EC, Sandeen MA, Liotta LA. In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res 1992; 52: 3208-12.
76. Enfissi A, Prigent S, Colosetti P, Capiod T. The blocking of capacitative calcium entry by 2-aminoethyl diphenylborate (2-APB) and carboxyamidotriazole (CAI) inhibits proliferation in Hep G2 and Huh-7 human hepatoma cells. Cell Calcium 2004; 36: 459-67.
77. Moody TW, Chiles J, Moody E, Sieczkiewicz GJ, Kohn EC. CAI inhibits the growth of small cell lung cancer cells. Lung Cancer 2003; 39: 279-88.
78. Bauer KS, Cude KJ, Dixon SC, Kruger EA, Figg W. Carboxyamido-triazole inhibits angiogenesis by blocking the calciummediated nitric-oxide synthase-vascular endothelial growth factor pathway. J Pharmacol Exp Ther 2000; 292: 31-37.
79. Faehling M, Kroll J, Fohr KJ, et al. Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J 2002; 16: 1805-07.
80. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 2000; 81: 1415-59.
81. 2+-entry pathways regulated by vasopressin. Biochem J 2003; 370: 439-48.
82. Mottola A, Antoniotti S, Lovisolo D, Munaron L. Regulation of non-capacitative calcium entry by arachidonic acid and nitric oxide in endothelial cells. The FASEB Journal express article 10.1096/fj.05-4110fje. Published online October 14, 2005.
83. 2+ influx. Biochem Biophys Res Commun 1998; 248: 635-40.
84. Kohn EC, Felder CC, Jacobs W, et al. Structure-function analysis of signal and growth inhibition by carboxyamidotriazole CAI. Cancer Res 1994; 54: 935.
85. Luzzi KJ, Varghese HJ, MacDonald IC, et al. Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI). Angiogenesis 1998; 2: 373-79.
86. Kohn EC, Reed E, Sarosy G, et al. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. Cancer Res 1996; 56: 569-73.
87. Kohn EC, Reed E, Sarosy GA, et al. A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction. Clin Cancer Res 2001; 7: 1600-09.
88. Hussain MM, Kotz H, Minasian L, et al. Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer, J Clin Oncol 2003; 21: 4356-63.
89. Franzius D, Hoth M, Penner R. Non-specific effects of calcium entry antagonists in mast cells. Pflugers Arch 1994; 428: 433-38.
90. Graier WF, Simecek S, Sturek M. Cytochrome P450 monooxygenase-regulated signalling of calcium entry in human and bovine endothelial cells. J Physiol 1995; 482: 259-74.
91. Hardie RC. Regulation of TRP channels via lipid second messengers, Annu Rev Physiol 2003; 65: 735-59.
92. Viana F, de Smedt H, Droogmans G, Nilius B. Calcium signaling through nucleotide receptor P2Y2 in cultured human vascular endothelium. Cell Calcium 1998; 24: 117-27.
93. Gamberucci A, Giurisato E, Pizzo P, et al. Diacylglycerol activates the influx of extracellular cations in T-lymphocytes independently of intracellular calcium-store depletion and possibly involving endogenous TRP6 gene products. Biochem J 2002; 364: 245-54.
94. Jan CR, Ho CM, Wu SN, Tseng CJ. Multiple effects of econazole on calcium signaling: depletion of thapsigarginsensitive calcium store, activation of extracellular calcium influx, and inhibition of capacitative calcium entry. Biochim Biophys Acta 1999; 1448: 533-42.
95. Jan CR, Tseng CJ. Mechanisms of miconazole-induced rise in cytoplasmic calcium concentrations in Madin Darby canine kidney (MDCK) cells. Life Sci 1999; 65: 2513-22.
96. 2+ signaling in Madin Darby canine kidney cells. Life Sci 2000; 66: 2289-96.
97. Snajdrova L, Xu A, Narayanan N. Clotrimazole, an antimycotic drug, inhibits the sarcoplasmic reticulum calcium pump and contractile function in heart muscle. J Biol Chem 1998; 273: 28032-39.
98. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95-105.
99. Sridhar SS, Seymour L, Shepherd FA. Inhibitors of epidermalgrowth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer. Lancet Oncol 2003; 4: 397-406.
100. Raicu M, Florea S, Costache G, Popov D, Simionescu M. Clotrimazole inhibits smooth muscle cell proliferation and has a vasodilator effect on resistance arteries. Fundam Clin Pharmacol 2000; 14: 477-85.
101. Soboloff J, Zhang Y, Minden M, Berger SA. Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging. Exp Hematol 2002; 30: 1219-26.
102. Benzaquen LR, Brugnara C, Byers HR, Gatton-Celli S, Halperin JA. Clotrimazole inhibits cell proliferation in vitro and in vivo. Nat Med 1995; 1: 534-40.
103. 2+ extrusion. Eur J Pharmacol 1990; 188: 417-21.
104. Magni M, Meldolesi J, Pandiella A. Ionic events induced by epidermal growth factor. Evidence that hyperpolarization and stimulated cation influx play a role in the stimulation of cell growth. J Biol Chem 1991; 266: 6329-35.
105. Merritt JE, Armstrong WP, Benham CD, et al. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 1990; 271: 515-22.
106. Chaib N, Kabre E, Metioui M, et al. Differential sensitivity to nickel and SK&F 96365 of second messenger-operated and receptor-operated calcium channels in rat submandibular ductal cells. Cell Calcium 1998; 23: 395-404.
107. Kan H, Ruan Y, Malik KU. Signal transduction mechanism(s) involved in prostacyclin production elicited by acetylcholine in coronary endothelial cells of rabbit heart. J Pharmacol Exp Ther 1997; 282: 113-22.
108. Schwartz G, Droogmans G, Nilius, B. Multiple effects of SK&F 96365 on ionic currents and intracellular calcium in human endothelial cells. Cell Calcium 1994; 15: 45-54.
109. 2+ entry in mouse mammary epithelial cells. Cell Biochem Funct 2001; 19: 213-19.
110. Krautwurst D, Hescheler J, Arndts D, Losel W, Hammer R, Schultz G. Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells. Mol Pharmacol 1993; 43: 655-59.
111. 2+ entry pathway in human endothelial cells by the isoquinoline derivative LOE 908. Br J Pharmacol 1996; 119: 702-706.
112. 2+) channels involved in endothelin-induced mitogenic response in carotid artery vascular smooth muscle cells. Am J Physiol Cell Physiol 2002; 282: C330-37.
113. 2+ influx on endothelin-1-induced intracellular mitogenic cascades in C6 glioma cells. Eur J Pharmacol 2002; 435: 119-23.
114. 2+ channels involved in endothelin-1-induced mitogenic responses in vascular smooth muscle cells. Eur J Pharmacol 2001; 422: 15-21.
115. 2+) influx through nonselective cation channel on noradrenalineinduced mitogenic responses. Eur J Pharmacol 2002; 447: 31-36.
116. Estacion M & L Mordan. PDGF stimulated calcium influx changes during in vitro cell transformation. Cell Signall 1997; 9: 363-66.
117. Rozengurt E. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists. J Cell Physiol 1998; 177: 507-17.
118. Munaron L, Antoniotti A, Fiorio Pla A, Lovisolo D. Blocking calcium entry: a way to control cell proliferation. Curr Med Chem 2004; 11: 1533-43.
119. Munaron L, Antoniotti A, Lovisolo D. Intracellular calcium signals and control of cell proliferation: how many mechanisms? J Cell Mol Med 2004; 8: 161-68.
120. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP. Estrogen-induced activation of mitogenactivated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci USA 1999; 96: 4686-91.
121. Altmann, K.H., Bold, G., Furet, P. et al.: US6878720 (2005).
122. 2+ and Ras signalling pathways. Biochim Biophys Acta 1998; 1448: 171-82.
123. Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms, Immunol Rev 2000; 176: 154-70.
124. 2+ stores, J Biol Chem 1992; 267: 108-18.
125. Munaron L, Antoniotti S, Distasi C, Lovisolo D. Arachidonic acid mediates calcium influx induced by basic fibroblast growth factor in Balb-c 3T3 fibroblasts. Cell Calcium 1997; 22: 179-88.
126. Ghitescu L, Robert M. Diversity in unity: the biochemical composition of the endothelial cell surface varies between the vascular beds. Microsc Res Tech 2002; 57: 381-89.
127. Distler JHW, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003; 47: 149-161.
128. Chang, J.-K.: US6835806 (2004).
129. Holmgren, L., Troyanovsky, B.: US6908898 (2005).
130. Chillemi, F., Francescato, P., Ziche, M.: US6921749 (2005).
131. 2+ signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin. Am J Physiol Cell Physiol 2001; 280: C1140-50.
132. Kim KS, Hong YK, Lee Y, et al. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain. Exp Mol Med 2003; 35: 578-85.
133. Piomelli D. Arachidonic acid in cell signaling. Curr Opin Cell Biol 1993; 5: 274-280.
134. Rizzo MA, Romero G. Pharmacological importance of phospholipase D and phosphatidic acid in the regulation of the mitogen-activated protein kinase cascade. Pharmacol Ther 2002; 94: 35-50.
135. Six DA, Dennis EA. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 2000; 1488: 1-19.
136. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993; 72: 269-273.
137. 2+-dependent translocation domain with homology to PKC and GAP. Cell 1991; 85: 1043-4051.
138. Sanchez T, Moreno JJ. Calcium-independent phospholipase A2 through arachidonic acid mobilization is involved in caco-2 cell growth. J Cell Physiol 2002; 193: 293-298.
139. Javerzat S, Auguste P, Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends Mol Med 2002; 8: 483-489.
140. Barrett KE, Bigby TD. New roles of eicosanoids as regulators of epithelial function and growth. NIPS 1995; 10: 153-159.
141. Kurakata, S., Hanai, M., Kanai, S., Kimura, T.: US6887893 (2005).
142. Dethlefsen SM, Shepro D, D'Amore PA. Arachidonic acid metabolites in bFGF-, PDGF-, and serum-stimulated vascular cell growth. Exp Cell Res 1994; 212: 262-273.
143. 2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem 1995; 270: 2360-2366.
144. Fafeur V, Zhi PJ, Bohlen P. Signal transduction by bFGF, but not TGF beta 1, involves arachidonic acid metabolism in endothelial cells. J Cell Physiol 1991; 149: 277-283.
145. Nie D, Tang K, Diglio C, Honn KV. Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase. Blood 2000; 95: 2304-2311.
146. Dormond O, Foletti A, Paroz C, Ruegg C. NSAIDs inhibit [VV3 integrin-mediated and Cdc42/Rac-dependent endothelial cell spreading, migration and angiogenesis. Nature Med 2001; 7: 1041-1047.
147. Merle PL, Feige JJ, Verdetti J. Basic fibroblast growth factor activates calcium channels in neonatal rat cardiomyocytes. J Biol Chem 1995; 270: 17361-7.
148. Distasi C, Torre M, Antoniotti S, Munaron L, Lovisolo D, Neuronal survival and calcium influx induced by basic fibroblast growth factor in chick ciliary ganglion neuron, Eur J Neurosci 1998; 10: 2276-2286.
149. Kiselyov K, Xu X, Mozhayeva G, et al. Functional interaction between InsP3 receptors and store-operated Htrp3 channels. Nature 1998; 396: 478-82.
150. 2+ entry channels. J Biol Chem 2001; 276: 18888-96.
151. Kopelman, R., Clark, H., Barker, S.: US6636652 (2003).
152. Enikolopov, G.N., Peunova, N.I., Kuzin, B.A., Cline, H., Michurina, T.: US6849662 (2005).
153. Cooke JP. NO and angiogenesis. Atheroscler Suppl. 2003; 4: 53-60.
154. Hood JD, Meininger C J, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998; 274: H1054-H1058.
155. van der Zee R, Murohara T, Luo Z, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997; 95: 1030-1037.
156. Inoue N, Venema RC, Sayegh HS, Ohara Y, Murphy TJ, Harrison DG. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol 1995; 15: 1255-1261.
157. Wu HM, Yuan Y, McCarthy M, Granger HJ. Acidic and basic FGFs dilate arterioles of skeletal muscle through a NOdependent mechanism. Am J Physiol 1996; 27: H1087-H1093.
158. Tiefenbacher CP, Chilian WM. Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation. Cardiovasc Res 1997; 34: 411-417.
159. Babaei S, Teichert-Kuliszewska K, Monge JC, Mohamed F, Bendeck MP, Stewart DJ. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res 1998; 82: 1007-1015.
160. Papapetropoulos A, Garcia Cardena G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997; 100: 3131-3139.
161. Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-2634.
162. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-5.
163. Rossig L, Fichtlscherer B, Breitschopf, K, et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 1999; 274: 6823-6826.
164. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996; 270: H411-H41.
165. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, Ahmed A. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 2001; 159: 993-1008.
166. Ziche M, Morbidelli L, Masini E, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94: 2036-2044
167. Murohara T, Witzenbichler B, Spyridopoulos I, et al. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 1999; 19: 1156-1161.
168. Noiri E, Lee E, Testa J, et al. Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol 1998; 274: C236-44.
169. Hudlicka O. Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation 1998; 5: 5-23
170. 2+ entry into vascular endothelial cells. FASEB J 2000; 14: 932-938.
171. Dulak J, Jozkowicz A, Dembinska-Kiec A, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000; 20: 659-666.
172. Fleming I, Busse R. Signal transduction of eNOS activation. Cardiovasc Res 43; 1999: 532-541.
173. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol 2003; 284: R1-12.
174. 2+ mobilizing properties for nitric oxide production in aortic endothelium. Life Sci 2002; 72: 511-20.
175. 2+ entry. J Biol Chem 2000; 275: 17979-17985
176. Fulton D, Gratton JP, McCabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999; 399: 597-601.
177. 2+: a negative feedback control. Trends Pharmacol Sci 2003; 24: 263-266
178. Zhang W, Couldwell W. T, Song H, Takano T, Lin JHC, Nedergaard M. Cancer Res 2000; 60: 5395-5400.
179. Berkels R, Suerhoff S, Roesen R, Klaus W, Nitric oxide causes a cGMP-independent intracellular calcium rise in porcine endothelial cells-a paradox? Microvasc Res 2000; 59: 38-44.
180. Gandino L, Munaron L, Naldini L, Ferracini R, Magni M, Comoglio PM. Intracellular calcium regulates the tyrosine kinase receptor encoded by the MET oncogene. J Biol Chem 1991; 266: 16098-16104.
181. Epstein R. Calcium-inducible transmodulation of receptor tyrosine kinase activity. Cell Signal 1995; 7: 377-388.
182. Takahashi A, Camacho P, Lechleiter JD, Herman B. Measurement of intracellular calcium. Physiol Rev 1999; 79: 1089-125.
183. Rizzuto R, Pinton P, Brini M, Chiesa C, Filippin L, Pozzan T. Mitochondria as biosensors of calcium microdomains. Cell Calcium 1999; 26: 193-199.
184. Pozzan T, Magalhães P, Rizzuto R. The comeback of mitochondria to calcium signalling. Cell Calcium 2000; 28: 279-283.
185. 2+ signals. J Cell Sci 2001; 114: 2213-22.
186. 2+ signals in cellular signalling. Curr Mol Med. 2004; 4: 263-75.
187. 2+ release in vascular endothelial cells. Am J Physiol 1997; 273 1: C1775-1782.
188. 2+ entry in bovine vascular endothelial cells, J Physiol 1999; 514: 101-109.
189. Murphy, A.N., Stout, A.K.: US20050170329A1 (2005).
190. 2+ elevation during agonist stimulation. J Biol Chem 2003; 278: 10807-10815.
191. Isshiki M, Anderson RG. Calcium signal transduction from caveolae. Cell Calcium 1999; 26: 201-208.
192. Golilorsky MS, Li H, Brodsky S, Chen J. Relationship between caveolae and eNOS: everything in proximity and the proximity of everything. Am J Physiol 2002; 283: F1-F10.
193. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998; 392: 933-936.
194. Lin RZ, Chen J, Hu ZW, Hoffman BB. Phosphorylation of the cAMP response element-binding protein and activation of transcription by alpha1 adrenergic receptors. J Biol Chem 1998; 273: 30033-30038.
195. 2+ signaling and control of growth and proliferation. Biol Cell 2004; 96: 55-68.
196. Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nature Immunol 2001; 2: 316-324.